2020年11月10日
瑞迪博士实验室产能规划负责人阿尼尔•帕特尼先生参加了由HPCi媒体有限公司(HPCi Media Limited)于2020年11月10日举办的2020年《制造化学家》现场虚拟活动并发表了演讲。
Mr. Patni explained in depth both the equipment and best practices needed to develop and manufacture HPAPIs (Highly Potent Active Pharmaceutical Ingredients) through lab scale to full drug product development.
想要进一步了解活动和演示的细节,请 点击这里.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.